Filing Details
- Accession Number:
- 0000899243-18-002323
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2018-01-30 20:54:43
- Reporting Period:
- 2017-12-19
- Accepted Time:
- 2018-01-30 20:54:43
- Original Submission Date:
- 2017-12-20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1609809 | Seres Therapeutics Inc. | MCRB | Pharmaceutical Preparations (2834) | 274326290 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1643756 | G. John Aunins | C/O Seres Therapeutics, Inc. 200 Sidney Street Cambridge MA 02139 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-12-19 | 5,000 | $0.00 | 197,125 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-12-19 | 1,623 | $10.14 | 195,502 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Footnotes
- Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- Due to a clerical error, the reporting person's original Form 4 filed on December 20, 2017 set forth an incorrect amount of common stock beneficially owned by the reporting person following the reported transaction. This Form 4/A corrects the error and presents the correct number of common stock beneficially owned by the reporting person following the reported transaction.
Billionaire Hedge Funds
